Vaxcyte, Inc. (PCVX)

Vaxcyte Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	173.96	387.88	397.45	834.66	68.99
Short-Term Investments	1,387	1,359	682.78	96.72	176.99
Cash & Short-Term Investments	1,561	1,747	1,080	931.38	245.97
Cash Growth	-10.66%	61.75%	15.98%	278.65%	-36.31%
Other Current Assets	66.4	40.78	15.73	11.18	10.38
Total Current Assets	1,627	1,788	1,096	942.56	256.35
Net Property, Plant & Equipment	373.38	270.15	110.62	31.65	35.91
Long-Term Investments	881.66	1,388	162.68	26.55	27.12
Other Long-Term Assets	120.31	65.68	38.67	5.43	4.96
Total Assets	3,003	3,511	1,408	1,006	324.34
Accounts Payable	70.9	48.45	14.59	9.8	6.76
Accrued Expenses	128.72	85.84	123.64	24.82	16.68
Current Portion of Leases	6.12	5.89	7.11	5.91	5.28
Total Current Liabilities	205.75	140.18	145.34	40.53	28.72
Long-Term Leases	111.36	65.22	22.11	12.03	11.51
Other Long-Term Liabilities	0.1	0.1	-	0.01	0.1
Total Long-Term Liabilities	111.46	65.32	22.11	12.04	11.6
Total Liabilities	317.21	205.5	167.45	52.57	40.32
Common Stock	0.13	0.13	0.1	0.08	0.06
Additional Paid-in Capital	4,839	4,698	2,165	1,476	582.84
Accumulated Other Comprehensive Income	1.59	-3.87	0.18	-0.36	-0.24
Retained Earnings	-2,155	-1,388	-924.39	-522.13	-298.64
Shareholders' Equity	2,686	3,306	1,240	953.61	284.02
Total Liabilities & Equity	3,003	3,511	1,408	1,006	324.34
Total Debt	117.48	71.11	29.22	17.94	16.78
Net Cash (Debt)	1,443	1,676	1,051	913.44	229.19
Net Cash Growth	-13.88%	59.48%	15.06%	298.55%	-40.65%
Net Cash Per Share	10.61	13.74	10.82	14.08	4.41
Book Value	2,686	3,306	1,240	953.61	284.02
Book Value Per Share	19.73	27.10	12.77	14.70	5.47
Tangible Book Value	2,686	3,306	1,240	953.61	284.02
Tangible Book Value Per Share	19.73	27.10	12.77	14.70	5.47

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q